Literature DB >> 1648247

Importance of delta opioid receptors in maintaining high alcohol drinking.

J C Froehlich1, M Zweifel, J Harts, L Lumeng, T K Li.   

Abstract

We have previously reported that naloxone, a nonspecific opioid receptor antagonist, suppresses alcohol but not water consumption by male rats that have been genetically selected for high voluntary alcohol drinking. However, the identity of the specific opioid receptor subtype that may mediate alcohol drinking is not known. This paper reports that a selective delta opioid receptor antagonist is as effective as naloxone in suppressing alcohol consumption and that an enkephalinase inhibitor, which potentiates the action of endogenous enkephalins, increases alcohol intake. These results suggest that alcohol-induced activation of the endogenous enkephalinergic system, and occupation of delta opioid receptors, are involved in the maintenance of continued alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648247     DOI: 10.1007/bf02244246

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  39 in total

1.  Novel phenylpiperidine opioid antagonists and partial agonists: effects on fluid consumption.

Authors:  J D Leander; J C Hart; M A Lochner; M D Hynes; D M Zimmerman
Journal:  Eur J Pharmacol       Date:  1982-07-09       Impact factor: 4.432

2.  ICI 174864: a highly selective antagonist for the opioid delta-receptor.

Authors:  R Cotton; M G Giles; L Miller; J S Shaw; D Timms
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

3.  Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior.

Authors:  S A Lorens; S M Sainati
Journal:  Life Sci       Date:  1978-10-02       Impact factor: 5.037

4.  Studies in vivo with ICI 174864 and [D-Pen2, D-Pen5]enkephalin.

Authors:  A Cowan; X Z Zhu; F Porreca
Journal:  Neuropeptides       Date:  1985-02       Impact factor: 3.286

5.  Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO).

Authors:  L D Hirning; H I Mosberg; R Hurst; V J Hruby; T F Burks; F Porreca
Journal:  Neuropeptides       Date:  1985-02       Impact factor: 3.286

6.  Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.

Authors:  B Giros; C Gros; J C Schwartz; D Danvy; J C Plaquevent; L Duhamel; P Duhamel; A Vlaiculescu; J Costentin; J M Lecomte
Journal:  J Pharmacol Exp Ther       Date:  1987-11       Impact factor: 4.030

7.  Radioligands for probing opioid receptors.

Authors:  S J Paterson; A D Corbett; M G Gillan; H W Kosterlitz; A T McKnight; L E Robson
Journal:  J Recept Res       Date:  1984

8.  The contribution of intrinsic activity to the action of opioids in vitro.

Authors:  L Miller; J S Shaw; E M Whiting
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

9.  The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.

Authors:  B P Roques; M C Fournié-Zaluski; E Soroca; J M Lecomte; B Malfroy; C Llorens; J C Schwartz
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

10.  Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary.

Authors:  R Schulz; M Wüster; T Duka; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  45 in total

1.  Naloxone attenuation of ethanol-reinforced operant responding in infant rats in a re-exposure paradigm.

Authors:  Roberto Sebastián Miranda-Morales; Juan Carlos Molina; Norman E Spear; Paula Abate
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

2.  The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.

Authors:  H Zhang; H R Kranzler; B-Z Yang; X Luo; J Gelernter
Journal:  Mol Psychiatry       Date:  2007-07-10       Impact factor: 15.992

3.  Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  Minh P Lam; Harri Nurmi; Noora Rouvinen; Kalervo Kiianmaa; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-26       Impact factor: 4.530

4.  Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Authors:  Elise M Weerts; Gary S Wand; Hiroto Kuwabara; Cynthia A Munro; Robert F Dannals; John Hilton; J James Frost; Mary E McCaul
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

Review 5.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

6.  The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.

Authors:  Gary S Wand; Elise M Weerts; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

Review 7.  Pharmacogenetics of alcohol and alcohol dependence treatment.

Authors:  Henry R Kranzler; Howard J Edenberg
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

8.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

10.  Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion.

Authors:  J Broadbent; H V Linder; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.